Company: PMVP
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0000950170-25-067513
Chunk: 0

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-05-09
Form: 10-Q
Item: Item 1
Chunk 0
---
PMV Pharmaceuticals, Inc.

Condensed Consolidated Balance Sheets

(unaudited)

(in thousands, except share and per share amounts)

     March 31,2025 (unaudited)

     December 31,2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     51,341

     $
     40,876

     Marketable securities, current

     109,047

     128,578

     Prepaid expenses and other current assets

     3,111

     6,204

     Total current assets

     163,499

     175,658

     Property and equipment, net

     376

     409

     Marketable securities, noncurrent

     5,435

     13,843

     Right-of-use assets

     1,061

     1,143

     Other assets

     237

     235

     Total assets
      
     $
     170,608

     $
     191,288

     Liabilities and Stockholders’ Equity

     Current liabilities:

     Accounts payable
      
     $
     3,593

     $
     6,579

     Accrued expenses

     5,802

     7,439

     Operating lease liabilities, current

     364

     352

     Total current liabilities

     9,759

     14,370

     Operating lease liabilities, noncurrent

     742

     838

     Total liabilities

     10,501

     15,208

     Stockholders’ equity:

     Preferred stock, $0.00001 par value, 5,000,000 shares authorized at March 31, 2025 and December 31, 2024.  No shares issued or outstanding at March 31, 2025 and December 31, 2024.

     —

     —

     Common stock, $0.00001 par value, 1,000,000,000 shares authorized; 51,954,135 and 51,935,134 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively.

     —

     —

     Additional paid-in capital

     546,171

     544,653

     Accumulated deficit

     (386,148
     )

     (368,